Contact facts
Contract awards
29
As contracting staff
First SAM.gov record
Dec 6, 2022
Awards come from FPDS, which names the staff who created, approved or last changed an award without
saying which.
FPDS publishes their email address only; the name is the one it spells.
Contract awards and IDVs
Award
Awarded
Obligated
The overall objective of this contract is to assess the ability of AURAVAX therapeutics? (AURAVAX) novel mucosal…
75A50124C00054 · Auravax Therapeutics, Inc.
Sep 23, 2024
$749,999
Task order 2
75A50123F61002 · Advanced Technology International
Sep 29, 2023
$129,138,986
Wake forest - organ tissue equivalent (OTE) platform for vaccine testing
75A50124C00060 · Wake Forest University Health Sciences
Sep 30, 2024
$12,495,604
Lung-brain inflammatory nexus: microphysiological system, university of rochester
75A50124C00040 · University Of Rochester
Sep 1, 2024
$6,671,830
AOI #23+: host-based diagnostics - expansion of immunix platform for precision medicine in severe acute respiratory…
75A50125C00016 · Prenosis, Inc.
Sep 30, 2025
$20,000,000
MACH32- development of intramuscular tranexamic acid formulation
75A50124C00058 · Mach32 Inc.
Sep 27, 2024
$749,846
Research and development- AOI #16+ seeking to manufacture and obtain regulatory approval for the cytotracker BV, a…
75A50123C00028 · Rizlab Health Inc.
Aug 11, 2023
$2,483,472
Tiba biotech, LLC - AOI#25(FASTX) R & D for respiratory virus treatment using lung-targeted sirna delivery
75A50124C00014 · Tiba Biotech LLC
Apr 30, 2024
$726,389
Emory university- fluvid, a dry powder, inhaled, mrna-based treatment for influenza and covid
75A50124C00039 · Emory University
Aug 22, 2024
$490,376
Red queen therapeutics, INC - AOI#25(FASTX) R & D for rapid response platform for the development of a pan-influenza…
75A50124C00018 · Red Queen Therapeutics Inc.
May 10, 2024
$266,511
Nytricx, INC. R & D for prevention of ecmo circuit thrombosis and infection by surface release of nitric oxide (no) AOI…
75A50124C00048 · Nytricx, Inc.
Sep 3, 2024
$745,973
Grifols therapeutics LLC- ocular surface immunoglobulin in the management of vesicant agents injury
75A50124C00050 · Grifols Therapeutics LLC
Sep 27, 2024
$613,200
Redhill biopharma LTD-opaganib as host-directed therapeutic for ebola virus disease
75A50124C00059 · Redhill Biopharma LTD
Sep 27, 2024
$733,382
Amplitude therapeutics-a split-formulated trans-amplifying RNA encoded anti-neuraminidase monoclonal antibody
75A50124C00036 · Amplitude Therapeutics, Inc.
Aug 20, 2024
$732,813
R & D for endobronchial lavage (EBL) to prevent and treat lung damage from pulmonary chemical agents AOI #15…
75A50123C00031 · Isola Therapeutics Inc.
Jul 12, 2023
$749,999
Trustees of tufts college - AOI#16(lab at home) R & D for distance-based paper analytical device (DPAD) for multiplexed…
75A50124C00021 · Trustees Of Tufts College
May 30, 2024
$492,746
Renbio INC. - AOI#25(FASTX) R & D for MYO technology for DNA-based delivery of anti-influenza antibodies to large…
75A50124C00017 · Renbio, Inc.
Apr 29, 2024
$749,289
Eradivir INC. IND studies is to complete a package of GLP-compliant nonclinical safety studies that will support a…
75A50123C00039 · Eradivir Inc.
Sep 18, 2023
$749,165
Alamgir research INC. R & D for countering opioid respiratory depression via AI based drug repositioning and in-vitro…
75A50123C00016 · Alamgir Research Inc.
Apr 5, 2023
$399,991
R & D for repurposing FX06, a host-directed therapy, for treatment of severe disease in patients with sudan virus…
75A50123C00064 · Partner Therapeutics, Inc.
Sep 25, 2023
$748,039
HDT BIO corp - AOI #21 vaccine on demand: R & D use of lion-reprna in rapid response vaccine development
75A50123C00051 · HDT Bio Corp
Sep 22, 2023
$749,000
US biologic R & D for the development of a rapid-response oral influenza vaccine (AOI #6 BTN)
75A50121C00008 · US Biologic, Inc.
Jul 19, 2021
$664,774
Jumpcode genomics, INC. Crispr powered NGS agnostic diagnostic AOI #10: NGS-based agnostic diagnostic
75A50122C00020 · Jumpcode Genomics Inc.
Mar 25, 2022
$740,000
Nature's toolbox (NTX) R & D for demonstration of a novel, rapidly deployable RNA vaccine production platform AOI# 21…
75A50123C00020 · Natures Toolbox Inc.
Apr 17, 2023
$627,628
Trustees of columbia university vircapseq: a platform for detection of pandemic threats and differential diagnosis of…
75A50122C00012 · The Trustees Of Columbia University In The City Of New York
Mar 30, 2022
$749,000
Top vendors
Award value adds up the base and exercised options recorded for the contract awards naming
them. IDVs carry no value of their own.
Quick answers
Who is Anna Chiang?
Anna Chiang is a federal contracting contact at Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services). Contracting staff on 29 contract awards, from December 6, 2022 to September 30, 2026.
How do I contact Anna Chiang?
FPDS lists Anna Chiang's email anna.chiang@hhs.gov.
Which vendors has Anna Chiang awarded contracts to?
The vendors on the most contract awards and IDVs naming Anna Chiang are Mach32 Inc., Nytricx, Inc. and Advanced Technology International. Anna Chiang's contract awards to Mach32 Inc. add up to $750K in base and exercised options.
On GovTribe
See Anna Chiang's full record
Every notice, award and file that names them
Their buying profile: what they buy and from whom
Export contacts at this office
Ask GovTribe AI about this contact
Government buyer contacts on GovTribe
Office of the Assistant Secretary for Preparedness and Response Department of Health and Human Services